Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andersson MHL"'
Autor:
Radford EJ; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.; Department of Paediatrics, University of Cambridge, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Tan HK; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Andersson MHL; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Stephenson JD; EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, UK., Gardner EJ; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Ironfield H; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Waters AJ; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Gitterman D; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Lindsay S; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Abascal F; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Martincorena I; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Kolesnik-Taylor A; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK., Ng-Cordell E; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.; Department of Psychology, University of British Columbia, Vancouver, Canada., Firth HV; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Baker K; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Perry JRB; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Adams DJ; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Gerety SS; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Hurles ME; Wellcome Sanger Institute, Hinxton, CB10 1SA, UK. meh@sanger.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Dec 06; Vol. 14 (1), pp. 7702. Date of Electronic Publication: 2023 Dec 06.
Autor:
Levitin MO; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Evox Therapeutics Limited, Oxford OX4 4HG, UK., Rawlins LE; RILD Wellcome Wolfson Medical Research Centre, University of Exeter, Exeter EX2 5DW, UK.; Peninsula Clinical Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter EX1 2ED, UK., Sanchez-Andrade G; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Arshad OA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Collins SC; INSERM Unit 1231, Université de Bourgogne Franche-Comté, Dijon 21078, France., Sawiak SJ; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge CB2 3EB, UK.; Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK., Iffland PH 2nd; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Andersson MHL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Bupp C; Spectrum Health, Helen DeVos Children's Hospital, Grand Rapids, MI 49503, USA., Cambridge EL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Coomber EL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Ellis I; Department of Clinical Genetics, Alder Hey Children's Hospital, Liverpool L14 5AB, UK., Herkert JC; Department of Genetics, University Medical Centre, University of Groningen, Groningen 9713 GZ, The Netherlands., Ironfield H; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Jory L; Haven Clinical Psychology Practice Ltd, Bude, Cornwall EX23 9HP, UK., Kretz PF; IGBMC, UMR7104, INSERM, Illkirch 67404, France., Kant SG; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands., Neaverson A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK., Nibbeling E; Laboratory for Diagnostic Genome Analysis, Department of Clinical Genetics, Leiden University Medical Center, Leiden 3015 GD, The Netherlands., Rowley C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Institute of Metabolic Science, Cambridge University, Cambridge CB2 0QQ, UK., Relton E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7YH, UK., Sanderson M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Scott EM; New Leaf Center, Clinic for Special Children, Mount Eaton, OH 44659, USA., Stewart H; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford OX3 7HE, UK., Shuen AY; London Health Sciences Centre, London, ON N6A 5W9, Canada.; Division of Medical Genetics, Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5W9, Canada., Schreiber J; Department of Neurology, Children's National Medical Center, Washington DC 20007, USA., Tuck L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Tonks J; Haven Clinical Psychology Practice Ltd, Bude, Cornwall EX23 9HP, UK., Terkelsen T; Department of Clinical Genetics, Aarhus University Hospital, Aarhus DK-8200, Denmark., van Ravenswaaij-Arts C; Department of Genetics, University Medical Centre, University of Groningen, Groningen 9713 GZ, The Netherlands., Vasudevan P; Department of Clinical Genetics, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester LE1 7RH, UK., Wenger O; New Leaf Center, Clinic for Special Children, Mount Eaton, OH 44659, USA., Wright M; Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne NE1 7RU, UK., Day A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Qkine Ltd., Cambridge CB5 8HW, UK., Hunter A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Patel M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Lelliott CJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Institute of Metabolic Science, Cambridge University, Cambridge CB2 0QQ, UK., Crino PB; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Yalcin B; INSERM Unit 1231, Université de Bourgogne Franche-Comté, Dijon 21078, France., Crosby AH; RILD Wellcome Wolfson Medical Research Centre, University of Exeter, Exeter EX2 5DW, UK., Baple EL; RILD Wellcome Wolfson Medical Research Centre, University of Exeter, Exeter EX2 5DW, UK.; Peninsula Clinical Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter EX1 2ED, UK., Logan DW; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Waltham Petcare Science Institute, Waltham on the Wolds LE14 4RT, UK., Hurles ME; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Gerety SS; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Publikováno v:
Brain : a journal of neurology [Brain] 2023 Nov 02; Vol. 146 (11), pp. 4766-4783.
Autor:
Neaverson A; Wellcome Sanger Institute, Cambridge, United Kingdom.; Open Targets, Wellcome Genome Campus, Hinxton, United Kingdom., Andersson MHL; Wellcome Sanger Institute, Cambridge, United Kingdom., Arshad OA; Wellcome Sanger Institute, Cambridge, United Kingdom., Foulser L; Wellcome Sanger Institute, Cambridge, United Kingdom.; Open Targets, Wellcome Genome Campus, Hinxton, United Kingdom., Goodwin-Trotman M; Wellcome Sanger Institute, Cambridge, United Kingdom., Hunter A; Wellcome Sanger Institute, Cambridge, United Kingdom., Newman B; Wellcome Sanger Institute, Cambridge, United Kingdom., Patel M; Wellcome Sanger Institute, Cambridge, United Kingdom., Roth C; UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Thwaites T; Wellcome Sanger Institute, Cambridge, United Kingdom., Kilpinen H; Wellcome Sanger Institute, Cambridge, United Kingdom.; Open Targets, Wellcome Genome Campus, Hinxton, United Kingdom.; UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.; Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland., Hurles ME; Wellcome Sanger Institute, Cambridge, United Kingdom.; Open Targets, Wellcome Genome Campus, Hinxton, United Kingdom., Day A; Wellcome Sanger Institute, Cambridge, United Kingdom., Gerety SS; Wellcome Sanger Institute, Cambridge, United Kingdom.; Open Targets, Wellcome Genome Campus, Hinxton, United Kingdom.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Jan 05; Vol. 10, pp. 1023340. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2022).